| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/1531-8257(200001)15:1<9::AID-MDS1004>3.0.CO;2-5 |
| P698 | PubMed publication ID | 10634236 |
| P2093 | author name string | Latchman DS | |
| Coffin RS | |||
| P2860 | cites work | GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons | Q24336322 |
| Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) | Q28202629 | ||
| Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse | Q34308944 | ||
| Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence | Q34779144 | ||
| Human gene therapy comes of age. | Q36220668 | ||
| Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. | Q36561684 | ||
| Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection | Q36720691 | ||
| Herpes simplex virus Vmw65-octamer binding protein interaction: a paradigm for combinatorial control of transcription | Q38310979 | ||
| Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor | Q38336118 | ||
| An inquiry into the mechanisms of herpes simplex virus latency | Q39159400 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. | Q40954651 | ||
| Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector | Q40973614 | ||
| Gene transfer to neurons using herpes simplex virus-based vectors | Q41132657 | ||
| Prospects for gene therapy in Parkinson's disease | Q41159915 | ||
| Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease | Q41169846 | ||
| Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS. | Q41186665 | ||
| Fetal nigral transplantation as a therapy for Parkinson's disease | Q41367101 | ||
| Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders | Q41543685 | ||
| Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA | Q41649774 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Pathways of viral gene expression during acute neuronal infection with HSV-1 | Q44933537 | ||
| Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1. | Q45885582 | ||
| A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons | Q46135759 | ||
| Induction of midbrain dopaminergic neurons by Sonic hedgehog | Q46258125 | ||
| Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa | Q46578408 | ||
| Adrenaline enhances odorant contrast by modulating signal encoding in olfactory receptor cells | Q48242457 | ||
| Intracerebral transplants of primary muscle cells: a potential 'platform' for transgene expression in the brain | Q48508816 | ||
| Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. | Q54647282 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| vector-borne disease | Q2083837 | ||
| P304 | page(s) | 9-17 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Viral vectors in the treatment of Parkinson's disease | |
| P478 | volume | 15 |
| Q37696495 | Future of cell and gene therapies for Parkinson's disease |
| Q34179305 | Gene delivery and gene therapy with herpes simplex virus-based vectors |
| Q45875373 | Gene therapy to the rescue in Parkinson's disease |
| Q34476794 | Gene therapy with herpes simplex virus vectors: progress and prospects for clinical neuroscience |
| Q34375860 | Genetic engineering within the adult brain: implications for molecular approaches to behavioral neuroscience |
| Q39126802 | Nanobiomaterials' applications in neurodegenerative diseases |
Search more.